ID S35A1_MOUSE Reviewed; 336 AA. AC Q61420; A2AT44; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 24-JAN-2024, entry version 154. DE RecName: Full=CMP-sialic acid transporter {ECO:0000303|PubMed:8755516}; DE Short=CMP-SA-Tr {ECO:0000303|PubMed:8755516}; DE Short=CMP-Sia-Tr; DE Short=CST {ECO:0000303|PubMed:30985278}; DE AltName: Full=Solute carrier family 35 member A1; GN Name=Slc35a1 {ECO:0000312|MGI:MGI:1345622}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, TISSUE RP SPECIFICITY, AND TRANSPORTER ACTIVITY. RX PubMed=8755516; DOI=10.1073/pnas.93.15.7572; RA Eckhardt M., Muehlenhoff M., Bethe A., Gerardy-Schahn R.; RT "Expression cloning of the Golgi CMP-sialic acid transporter."; RL Proc. Natl. Acad. Sci. U.S.A. 93:7572-7576(1996). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=FVB/N; TISSUE=Salivary gland; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, SUBCELLULAR LOCATION, MEMBRANE TOPOLOGY, AND TRANSPORTER RP ACTIVITY. RX PubMed=10085119; DOI=10.1074/jbc.274.13.8779; RA Eckhardt M., Gotza B., Gerardy-Schahn R.; RT "Membrane topology of the mammalian CMP-sialic acid transporter."; RL J. Biol. Chem. 274:8779-8787(1999). RN [5] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Kidney, and Pancreas; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [6] RP FUNCTION, TRANSPORTER ACTIVITY, AND MUTAGENESIS OF MET-20; ALA-24; TYR-27; RP ALA-105; GLN-118; TYR-121; GLN-122; ALA-184; ALA-253; GLY-256 AND THR-260. RX PubMed=34015330; DOI=10.1016/j.jbc.2021.100789; RA Ury B., Potelle S., Caligiore F., Whorton M.R., Bommer G.T.; RT "The promiscuous binding pocket of SLC35A1 ensures redundant transport of RT CDP-ribitol to the Golgi."; RL J. Biol. Chem. 296:100789-100789(2021). RN [7] RP SUBCELLULAR LOCATION, AND MUTAGENESIS OF VAL-336. RX PubMed=15932921; DOI=10.1093/glycob/cwi085; RA Kabuss R., Ashikov A., Oelmann S., Gerardy-Schahn R., Bakker H.; RT "Endoplasmic reticulum retention of the large splice variant of the UDP- RT galactose transporter is caused by a dilysine motif."; RL Glycobiology 15:905-911(2005). RN [8] RP X-RAY CRYSTALLOGRAPHY (2.58 ANGSTROMS) OF 1-322 IN COMPLEX WITH CMP-SIALIC RP ACID, FUNCTION, TOPOLOGY, MUTAGENESIS OF 322-SER--VAL-336, TRANSPORTER RP ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=30985278; DOI=10.7554/elife.45221; RA Ahuja S., Whorton M.R.; RT "Structural basis for mammalian nucleotide sugar transport."; RL Elife 8:0-0(2019). CC -!- FUNCTION: Transports CMP-sialic acid from the cytosol into the Golgi CC apparatus, functioning as an antiporter that exchanges CMP-sialic acid CC for CMP (PubMed:8755516, PubMed:10085119, PubMed:30985278, CC PubMed:34015330). Binds both CMP-sialic acid and free CMP, but has CC higher affinity for free CMP (PubMed:30985278). Also able to exchange CC CMP-sialic acid for AMP and UMP (By similarity). Also mediates the CC transport of CDP-ribitol (PubMed:34015330) (By similarity). CC {ECO:0000250|UniProtKB:P78382, ECO:0000269|PubMed:10085119, CC ECO:0000269|PubMed:30985278, ECO:0000269|PubMed:34015330, CC ECO:0000269|PubMed:8755516}. CC -!- CATALYTIC ACTIVITY: CC Reaction=CMP(out) + CMP-N-acetyl-beta-neuraminate(in) = CMP(in) + CMP- CC N-acetyl-beta-neuraminate(out); Xref=Rhea:RHEA:67724, CC ChEBI:CHEBI:57812, ChEBI:CHEBI:60377; CC Evidence={ECO:0000269|PubMed:10085119, ECO:0000269|PubMed:30985278, CC ECO:0000269|PubMed:34015330, ECO:0000269|PubMed:8755516}; CC -!- CATALYTIC ACTIVITY: CC Reaction=AMP(out) + CMP-N-acetyl-beta-neuraminate(in) = AMP(in) + CMP- CC N-acetyl-beta-neuraminate(out); Xref=Rhea:RHEA:74639, CC ChEBI:CHEBI:57812, ChEBI:CHEBI:456215; CC Evidence={ECO:0000250|UniProtKB:P78382}; CC -!- CATALYTIC ACTIVITY: CC Reaction=CDP(out) + CDP-L-ribitol(in) = CDP(in) + CDP-L-ribitol(out); CC Xref=Rhea:RHEA:71579, ChEBI:CHEBI:57608, ChEBI:CHEBI:58069; CC Evidence={ECO:0000269|PubMed:34015330}; CC -!- CATALYTIC ACTIVITY: CC Reaction=CMP-N-acetyl-beta-neuraminate(in) + UMP(out) = CMP-N-acetyl- CC beta-neuraminate(out) + UMP(in); Xref=Rhea:RHEA:74643, CC ChEBI:CHEBI:57812, ChEBI:CHEBI:57865; CC Evidence={ECO:0000250|UniProtKB:P78382}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=13.2 uM for CMP-N-acetyl-beta-neuraminate CC {ECO:0000269|PubMed:30985278}; CC Vmax=6.5 nmol/min/mol enzyme for CMP-N-acetyl-beta-neuraminate CC {ECO:0000269|PubMed:30985278}; CC -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P78382}. CC -!- SUBCELLULAR LOCATION: Golgi apparatus membrane CC {ECO:0000269|PubMed:10085119, ECO:0000269|PubMed:15932921, CC ECO:0000269|PubMed:8755516}; Multi-pass membrane protein CC {ECO:0000269|PubMed:10085119}. CC -!- TISSUE SPECIFICITY: Ubiquitous. Found in all the tissues examined CC including skeletal muscle, brain, heart, liver, kidney and spleen. CC {ECO:0000269|PubMed:8755516}. CC -!- SIMILARITY: Belongs to the nucleotide-sugar transporter family. SLC35A CC subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Z71268; CAA95855.1; -; mRNA. DR EMBL; AL928738; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC012252; AAH12252.1; -; mRNA. DR CCDS; CCDS18030.1; -. DR RefSeq; NP_036025.2; NM_011895.3. DR PDB; 6OH2; X-ray; 2.58 A; A=1-322. DR PDB; 6OH3; X-ray; 2.75 A; A=1-322. DR PDB; 6OH4; X-ray; 3.38 A; A/B=1-336. DR PDB; 6XBO; X-ray; 1.80 A; A=1-322. DR PDBsum; 6OH2; -. DR PDBsum; 6OH3; -. DR PDBsum; 6OH4; -. DR PDBsum; 6XBO; -. DR AlphaFoldDB; Q61420; -. DR SMR; Q61420; -. DR STRING; 10090.ENSMUSP00000029970; -. DR TCDB; 2.A.7.12.1; the drug/metabolite transporter (dmt) superfamily. DR iPTMnet; Q61420; -. DR PhosphoSitePlus; Q61420; -. DR EPD; Q61420; -. DR MaxQB; Q61420; -. DR PaxDb; 10090-ENSMUSP00000029970; -. DR ProteomicsDB; 260771; -. DR Pumba; Q61420; -. DR Antibodypedia; 46448; 30 antibodies from 13 providers. DR DNASU; 24060; -. DR Ensembl; ENSMUST00000029970.14; ENSMUSP00000029970.8; ENSMUSG00000028293.15. DR GeneID; 24060; -. DR KEGG; mmu:24060; -. DR UCSC; uc012dbo.1; mouse. DR AGR; MGI:1345622; -. DR CTD; 10559; -. DR MGI; MGI:1345622; Slc35a1. DR VEuPathDB; HostDB:ENSMUSG00000028293; -. DR eggNOG; KOG2234; Eukaryota. DR GeneTree; ENSGT00950000182827; -. DR HOGENOM; CLU_024645_1_0_1; -. DR InParanoid; Q61420; -. DR OMA; QATKVQM; -. DR OrthoDB; 200085at2759; -. DR PhylomeDB; Q61420; -. DR TreeFam; TF315345; -. DR Reactome; R-MMU-4085001; Sialic acid metabolism. DR Reactome; R-MMU-727802; Transport of nucleotide sugars. DR BioGRID-ORCS; 24060; 27 hits in 83 CRISPR screens. DR ChiTaRS; Slc35a1; mouse. DR PRO; PR:Q61420; -. DR Proteomes; UP000000589; Chromosome 4. DR RNAct; Q61420; Protein. DR Bgee; ENSMUSG00000028293; Expressed in conjunctival fornix and 255 other cell types or tissues. DR ExpressionAtlas; Q61420; baseline and differential. DR GO; GO:0000139; C:Golgi membrane; IDA:UniProtKB. DR GO; GO:0016020; C:membrane; IDA:UniProtKB. DR GO; GO:0015297; F:antiporter activity; IDA:UniProtKB. DR GO; GO:0005456; F:CMP-N-acetylneuraminate transmembrane transporter activity; IDA:UniProtKB. DR GO; GO:0008643; P:carbohydrate transport; IEA:UniProtKB-KW. DR GO; GO:0015782; P:CMP-N-acetylneuraminate transmembrane transport; IDA:UniProtKB. DR InterPro; IPR007271; Nuc_sug_transpt. DR NCBIfam; TIGR00803; nst; 1. DR PANTHER; PTHR10231:SF66; CMP-SIALIC ACID TRANSPORTER; 1. DR PANTHER; PTHR10231; NUCLEOTIDE-SUGAR TRANSMEMBRANE TRANSPORTER; 1. DR Pfam; PF04142; Nuc_sug_transp; 1. DR PIRSF; PIRSF005799; UDP-gal_transpt; 1. DR SUPFAM; SSF103481; Multidrug resistance efflux transporter EmrE; 1. DR Genevisible; Q61420; MM. PE 1: Evidence at protein level; KW 3D-structure; Antiport; Golgi apparatus; Membrane; Reference proteome; KW Sugar transport; Transmembrane; Transmembrane helix; Transport. FT CHAIN 1..336 FT /note="CMP-sialic acid transporter" FT /id="PRO_0000213352" FT TOPO_DOM 1..9 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:10085119, FT ECO:0000269|PubMed:30985278" FT TRANSMEM 10..30 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 31..45 FT /note="Lumenal" FT /evidence="ECO:0000269|PubMed:30985278" FT TRANSMEM 46..64 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 65..87 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:30985278" FT TRANSMEM 88..108 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 109..114 FT /note="Lumenal" FT /evidence="ECO:0000269|PubMed:30985278" FT TRANSMEM 115..135 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 136..141 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:30985278" FT TRANSMEM 142..160 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 161..175 FT /note="Lumenal" FT /evidence="ECO:0000269|PubMed:30985278" FT TRANSMEM 176..196 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 197..209 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:30985278" FT TRANSMEM 210..228 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 229..243 FT /note="Lumenal" FT /evidence="ECO:0000269|PubMed:30985278" FT TRANSMEM 244..262 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 263..269 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:30985278" FT TRANSMEM 270..288 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 289..296 FT /note="Lumenal" FT /evidence="ECO:0000269|PubMed:30985278" FT TRANSMEM 297..315 FT /note="Helical" FT /evidence="ECO:0000269|PubMed:30985278" FT TOPO_DOM 316..336 FT /note="Cytoplasmic" FT /evidence="ECO:0000269|PubMed:10085119, FT ECO:0000269|PubMed:30985278" FT REGION 316..336 FT /note="Disordered" FT /evidence="ECO:0000269|PubMed:30985278" FT BINDING 55 FT /ligand="CMP-N-acetyl-beta-neuraminate" FT /ligand_id="ChEBI:CHEBI:57812" FT /evidence="ECO:0000269|PubMed:30985278, FT ECO:0007744|PDB:6OH2, ECO:0007744|PDB:6OH3" FT BINDING 101..102 FT /ligand="CMP-N-acetyl-beta-neuraminate" FT /ligand_id="ChEBI:CHEBI:57812" FT /evidence="ECO:0000269|PubMed:30985278, FT ECO:0007744|PDB:6OH2, ECO:0007744|PDB:6OH3" FT BINDING 117..124 FT /ligand="CMP-N-acetyl-beta-neuraminate" FT /ligand_id="ChEBI:CHEBI:57812" FT /evidence="ECO:0000269|PubMed:30985278, FT ECO:0007744|PDB:6OH2, ECO:0007744|PDB:6OH3" FT BINDING 188 FT /ligand="CMP-N-acetyl-beta-neuraminate" FT /ligand_id="ChEBI:CHEBI:57812" FT /evidence="ECO:0000269|PubMed:30985278, FT ECO:0007744|PDB:6OH2, ECO:0007744|PDB:6OH3" FT BINDING 210..214 FT /ligand="CMP-N-acetyl-beta-neuraminate" FT /ligand_id="ChEBI:CHEBI:57812" FT /evidence="ECO:0000269|PubMed:30985278, FT ECO:0007744|PDB:6OH2, ECO:0007744|PDB:6OH3" FT BINDING 272 FT /ligand="CMP-N-acetyl-beta-neuraminate" FT /ligand_id="ChEBI:CHEBI:57812" FT /evidence="ECO:0000269|PubMed:30985278, FT ECO:0007744|PDB:6OH2, ECO:0007744|PDB:6OH3" FT MUTAGEN 20 FT /note="M->S: No effect on CDP-ribitol and CMP-sialic acid FT transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 24 FT /note="A->Y: Loss of CMP-sialic acid transport activity but FT no effect on CDP-ribitol transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 27 FT /note="Y->H: No effect on CDP-ribitol and CMP-sialic acid FT transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 105 FT /note="A->V: No effect on CDP-ribitol and CMP-sialic acid FT transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 118 FT /note="Q->A: No effect on CDP-ribitol and CMP-sialic acid FT transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 121 FT /note="Y->S: No effect on CDP-ribitol and CMP-sialic acid FT transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 122 FT /note="Q->A: No effect on CDP-ribitol and CMP-sialic acid FT transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 184 FT /note="A->Y: Loss of CMP-sialic acid transport activity but FT no effect on CDP-ribitol transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 253 FT /note="A->Q: No effect on CDP-ribitol and CMP-sialic acid FT transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 256 FT /note="G->N: Loss of CMP-sialic acid transport activity but FT no effect on CDP-ribitol transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 260 FT /note="T->M: No effect on CDP-ribitol and CMP-sialic acid FT transport activity." FT /evidence="ECO:0000269|PubMed:34015330" FT MUTAGEN 322..336 FT /note="Missing: No effect on CMP-sialic acid transport FT activity." FT /evidence="ECO:0000269|PubMed:30985278" FT MUTAGEN 336 FT /note="V->VGSKVKGS: Results in localization to the FT endoplasmic reticulum." FT /evidence="ECO:0000269|PubMed:15932921" FT CONFLICT 18 FT /note="T -> A (in Ref. 1; CAA95855 and 3; AAH12252)" FT /evidence="ECO:0000305" FT CONFLICT 166 FT /note="T -> S (in Ref. 1; CAA95855 and 3; AAH12252)" FT /evidence="ECO:0000305" FT HELIX 10..36 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 44..67 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 70..80 FT /evidence="ECO:0007829|PDB:6XBO" FT TURN 81..83 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 85..111 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 114..121 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 124..135 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 142..159 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 174..199 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 206..236 FT /evidence="ECO:0007829|PDB:6XBO" FT TURN 238..241 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 244..266 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 269..291 FT /evidence="ECO:0007829|PDB:6XBO" FT HELIX 297..313 FT /evidence="ECO:0007829|PDB:6XBO" SQ SEQUENCE 336 AA; 36453 MW; A396528233904451 CRC64; MAPARENVSL FFKLYCLTVM TLVAAAYTVA LRYTRTTAEE LYFSTTAVCI TEVIKLLISV GLLAKETGSL GRFKASLSEN VLGSPKELAK LSVPSLVYAV QNNMAFLALS NLDAAVYQVT YQLKIPCTAL CTVLMLNRTL SKLQWISVFM LCGGVTLVQW KPAQATKVVV AQNPLLGFGA IAIAVLCSGF AGVYFEKVLK SSDTSLWVRN IQMYLSGIVV TLAGTYLSDG AEIQEKGFFY GYTYYVWFVI FLASVGGLYT SVVVKYTDNI MKGFSAAAAI VLSTIASVLL FGLQITLSFA LGALLVCVSI YLYGLPRQDT TSIQQEATSK ERIIGV //